CSIMarket Company Name, Ticker, Competitors, else..
 
Baxter International Inc   (NYSE: BAX)
Other Ticker:  
 
 

Baxter International Inc Growth Comparisons

Select each growth Category to receive further Information




 
BAX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) -26.92 % -3.68 % 2.84 % 3.73 %
Q / Q Revenue Growth (Q1 MRQ) 392.5 % 1.99 % -4.6 % -4.18 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) -34.47 % -3.11 % 5.47 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) -9.09 % -1.27 % 0.54 % 0.99 %
Revenue 5 Year Average Growth -1.31 % 6.17 % 8.2 % 7.6 %


BAX's Growth Comparisons in I. Quarter 2025




Baxter International Inc 's Revenue were slashed by -26.92% in the first quarter 2025 from the same quarter a year ago, to $ 2.63 billions, while sales in theMedical Equipment & Supplies industry fell only by -3.68%, and underperformed the 2.84% Revenue growth in the Healthcare sector. Weak first quarter sales, in Medical Equipment & Supplies industry and within the Healthcare sector, were reflected in Baxter International Inc results which underperformed overall market.

Company's sequential Revenue growth rate was impressive 392.5% from the forth quarter. Average yearly sales growth for Baxter International Inc is -1.31%, while S & P 500's average annual sales growth is 7.6% over the five years, including only Businesses with the first quarter 2025 financial reports.

BAX Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
2021
-
-
2022
-
-
2023
-
-
2024
-
-
2025
-
-
United States
10.53 %
-
International
-0.61 %
-
Medical Products Therapies
2.69 %
-
Healthcare Systems Technologies
5.55 %
-
Pharmaceuticals
0.52 %
-
United States Medical Products Therapies
8.32 %
-
United States Healthcare Systems Technologies
9.51 %
-
United States Pharmaceuticals
2.09 %
-
International Medical Products Therapies
-4.14 %
-
International Healthcare Systems Technologies
-4.12 %
-
International Pharmaceuticals
-0.26 %
-
Infusion Therapies and Technologies Medical Products Therapies
2.9 %
-
Infusion Therapies and Technologies United States Medical Products Therapies
11.03 %
-
Infusion Therapies and Technologies International Medical Products Therapies
-6.82 %
-
Advanced Surgery Medical Products Therapies
1.9 %
-
Advanced Surgery United States Medical Products Therapies
-1.36 %
-
Advanced Surgery International Medical Products Therapies
6.03 %
-
Care and Connectivity Solutions Healthcare Systems Technologies
6.22 %
-
Care and Connectivity Solutions United States Healthcare Systems Technologies
13.67 %
-
Care and Connectivity Solutions International Healthcare Systems Technologies
-10.48 %
-
Front Line Care Healthcare Systems Technologies
4.53 %
-
Front Line Care United States Healthcare Systems Technologies
3.59 %
-
Front Line Care International Healthcare Systems Technologies
7.14 %
-
Injectables and Anesthesia Pharmaceuticals
2.13 %
-
Injectables and Anesthesia United States Pharmaceuticals
2.09 %
-
Injectables and Anesthesia International Pharmaceuticals
2.19 %
-
Drug Compounding Pharmaceuticals
-1.6 %
-
Drug Compounding International Pharmaceuticals
-1.6 %
-
Other
387.5 %
-
Other United States
336.36 %
-
Other International
500 %
-
Emerging Markets
-3.26 %
-
Rest of world
0.36 %
-
Total
-26.92 %
-


Growth Rates of BAX's Income in the first quarter 2025


BAX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) -68.98 % -5.53 % 100.45 % 1.36 %
Sequential Operating Income Change (Q1 MRQ) - 96.72 % 36.61 % 14.45 %
Y / Y Operating Income Growth (Q1 TTM) - - 97.21 % 4.64 %
Sequential Operating Income Growth (Q1 TTM) - 1.33 % 17.86 % 0.41 %
Operating Income 5 Year Avg. Change -62.02 % -1.31 % -1.74 % 9.14 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) 64.1 % -3.22 % 715.13 % 14.68 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - 199.56 % 19.58 % 1.35 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - - 279.49 % 10.83 %
Sequential Income from Cont. Ops. Change (Q1 TTM) - 3.11 % 42.07 % 2.75 %
Income from Cont. Ops. 5 Year Avg. Change - -7.08 % -8.93 % 9.1 %

BAX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) 223.08 % -9.63 % 715.08 % 14.09 %
Q / Q Net Income Growth (Q1 MRQ) - 238.57 % 19.02 % 0.63 %
Y / Y Net Income Change (Q1 TTM) - 629.58 % 86.52 % 9.45 %
Sequential Net Income Change (Q1 TTM) - 0.37 % 39.78 % 2.65 %
Net Income 5 Year Avg. Growth - -3.85 % -8.52 % 8.66 %

BAX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 85.71 % -3.99 % 715.13 % 14.68 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - 192.72 % 19.58 % 1.35 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) - - - -23.98 %
EPS from Cont. Ops. 5 Year Avg. Growth - -14.71 % -8.93 % 9.1 %



BAX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 257.14 % -10.35 % 715.08 % 9.1 %
Q / Q EPS Net Growth (Q1 MRQ) - 230.84 % 19.02 % 0.63 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 0.15 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) - - - -23.99 %
EPS Net 5 Year Avg. Change - -3.85 % -8.52 % 8.66 %



Despite the -10.35% decline in Medical Equipment & Supplies industry, Baxter International Inc showed impressive surge in EPS in the first quarter by 257.14% from the same quarter a year ago, to $0.25, Healthcare sector surged 715.08%. Although Medical Equipment & Supplies industry's earnings per share were softer then 14.09% overall market growth, Baxter International Inc and the Healthcare sector have delivered above the average market earnings per share.

The Company's sequential EPS growth rate was very impressive 392.5% from the forth quarter. Average yearly income per share growth for Baxter International Inc is -1.31%, while S & P 500's average annual income per share growth is 8.66% over the five years, including only Businesses with the first quarter 2025 earnings results.

BAX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - -30.4 % -6.73 % -
Sequential Free Cash Flow Change (Q1 MRQ) - -69.73 % -58.47 % -
Y / Y Free Cash Flow Change (Q1 TTM) -52.98 % -9.91 % 12.06 % 4.18 %
Sequential Free Cash Flow Change (Q1 TTM) -34.94 % -2.54 % -0.62 % -4.62 %
Free Cash Flow 5 Year Avg. Change - 1 % 4.78 % 8.3 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - -80.72 % -97.04 % -
Sequential Net Cash Flow Change (Q1 MRQ) - - -92.58 % -
Y / Y Net Cash Flow Change (Q1 TTM) - - -90.04 % -
Sequential Net Cash Flow Change (Q1 TTM) - - -74.74 % -
Net Cash Flow 5 Year Avg. Change - 60.17 % -16.14 % 0.62 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -32.97 % -19.76 % 6.05 % 13.48 %
Sequential Capital Expenditures Change (Q1 MRQ) -0.81 % -21.58 % -19.17 % -19.47 %
Y / Y Capital Expenditures Change (Q1 TTM) -45.01 % -12.28 % 6.06 % 38.65 %
Sequential Capital Expenditures Change (Q1 TTM) -13.45 % -5.64 % 1.23 % 4.08 %
Capital Expenditures 5 Year Avg. Change 18.24 % 6.88 % 8.01 % 7.66 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com